(redirected from Immunosuppressive therapy)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to Immunosuppressive therapy: Immunosuppressive medications
See: treatment
References in periodicals archive ?
17) and highest in patients with a history of immunosuppressive therapy (0.
Patients who had had consultations with a pulmonary medicine or infectious disease specialist and who were suspected of having developed HAP according to the above criteria while receiving immunosuppressive therapy were included in this study.
The patient is currently well, 2 years posttransplant, and is maintained on standard posttransplant immunosuppressive therapy.
In the triple immunosuppressive therapy arm, patients will receive a standard course of chronic, maintenance CS therapy.
Although this assay is not yet able to facilitate the distinction of single drug effects pertaining to a multidrug immunosuppressive therapy after transplantation, our investigations clearly demonstrate that data on cytokine mRNA expression kinetics are necessary for adequate interpretation of the monitoring of both CsA monotherapy and CsA-based immunosuppressive triple therapy.
This case illustrates the complex nature of drug interactions that must be considered in the medical treatment of patients receiving immunosuppressive therapy.
All responded to immunosuppressive therapy, but many of them relapsed when the treatment was tapered (Arthritis Rheum.
She was on immunosuppressive therapy of prednisolone (5 mg/day), cyclosporine-A (trough levels of 100 ng/dL), and azathioprine (50 mg/day).
Thymoglobulin should only be used by physicians experienced in immunosuppressive therapy in the management of renal transplant patients.
In the future, the test might enable physicians to begin immunosuppressive therapy early, Trucco says.
Adding Soliris to Immunosuppressive Therapy Provided Clinical Benefit to Patients with Concomitant PNH and Aplastic Anemia in Study Presented at ASH Annual Meeting
The patients who achieved SVR received grafts from younger donors, received longer treatment duration and cumulative dose of interferon, and had a lower drop-out rate and lower incidence of diabetes; however, there were no differences in immunosuppressive therapy for the patients.